BSX
BOSTON SCIENTIFIC CORP
Key Financials
Gross Profit
$13.9B
↑ 20.6%
Net Income
$-1301000000
N/A
Operating Income
$3.6B
↑ 38.8%
Revenue
$20.1B
↑ 19.9%
EPS (Diluted)
$1.94
↑ 55.2%
Shareholders' Equity
$24.2B
↑ 11.3%
Total Assets
$43.7B
↑ 10.9%
Operating Cash Flow
$4.5B
↑ 32.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/18/2026 | View on SEC |
| 8-K | 5/18/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
| 4 | 5/11/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BSX |
| Company Name | BOSTON SCIENTIFIC CORP |
| CIK | 885725 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 508-683-4000 |